PTHS
AMEX · Biotechnology

Pelthos Therapeutics Inc

$25.65
-2.04 (-7.37%)
As of May 16, 2:16 AM ET ·
Financial Highlights (FY 2026)
Revenue
32.35M
Net Income
-83,445,626
Gross Margin
76.2%
Profit Margin
-257.9%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.2% 34.6% 34.6% 34.6%
Operating Margin -194.8% 15.6% 18.3% 16.9%
Profit Margin -257.9% 13.7% 13.1% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 32.35M 12.22M 12.16M 13.52M
Gross Profit 24.67M 4.22M 4.20M 4.67M
Operating Income -63,018,780 1.91M 2.23M 2.28M
Net Income -83,445,626 1.67M 1.59M 1.78M
Gross Margin 76.2% 34.6% 34.6% 34.6%
Operating Margin -194.8% 15.6% 18.3% 16.9%
Profit Margin -257.9% 13.7% 13.1% 13.2%
Rev Growth +12.4% +20.7% +15.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 35.24M 30.53M 34.79M
Total Equity 56.05M 48.64M 50.50M
D/E Ratio 0.63 0.63 0.69
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -60,012,213 2.79M 3.00M 3.51M
Free Cash Flow 1.30M 1.27M 1.44M